Christopher J. Gerard

Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards.

Christopher J. Gerard, K Olsson, Rajeev Ramanathan et al. · PubMed · 1998 · 120 citations

Immunocytochemical Technique, Immunology, Pathology +23

Dual Therapeutic Utility of Proteasome Modulating Agents for Pharmaco-gene Therapy of the Cystic Fibrosis Airway

Liang Zhang, Phil Karp, Christopher J. Gerard et al. · Molecular Therapy · 2004 · 49 citations · Full text

Protease Inhibitors, Gene Therapies, Inflammatory Lung Disease +15

A Rapid and Quantitative Assay to Estimate Gene Transfer into Retrovirally Transduced Hematopoietic Stem/Progenitor Cells Using a 96-Well Format PCR and Fluorescent Detection System Universal for MMLV-Based Proviruses

Christopher J. Gerard, M. Arboleda, Gregg P. Solar et al. · Human Gene Therapy · 1996 · 39 citations · Full text

96-Well Format Pcr, Cell Therapy, Engineering +23

Mitochondrial ATP Synthase 6 as an Endogenous Control in the Quantitative RT-PCR Analysis of Clinical Cancer Samples

Christopher J. Gerard, Laura Andrejka, Roberto A. Macina · Molecular Diagnosis · 2000 · 37 citations

Biochemistry, Mitochondrial Function, Medicine +9

Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine

Lauren M. Tatalick, Christopher J. Gerard, Ryan Takeya et al. · Vaccine · 2004 · 27 citations

Vaccination, Vaccine Development, Hela-based Cell Substrates +9